MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sunesis Pharmaceuticals Company Profile (NASDAQ:SNSS)

Consensus Ratings for Sunesis Pharmaceuticals (NASDAQ:SNSS) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.67 (204.30% upside)

Analysts' Ratings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Show:
DateFirmActionRatingPrice TargetActions
5/6/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Roth CapitalDowngradeBuy -> Sell$5.50 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015WedbushReiterated RatingHold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015BTIG ResearchInitiated CoverageBuy$5.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014RBC CapitalDowngradeOutperform -> Sector Perform$9.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2014Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
5/5/2016Q116($0.12)($0.12)$0.77 million$0.64 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2016Q415($0.14)($0.15)$0.84 million$0.67 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.12)($0.09)$1.09 million$0.68 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215($0.13)($0.15)$1.21 million$0.85 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.16)($0.13)$1.14 million$0.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2015Q414($0.20)($0.02)$1.17 million$0.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.17)($0.25)$1.97 million$0.85 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214($0.17)($0.20)$1.32 million$2.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.17)($0.26)$1.32 million$2.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q413($0.20)($0.15)$1.37 million$2.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2013Q313($0.20)($0.16)$1.44 million$1.99 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2013Q2 2013($0.21)$0.18$1.22 million$1.99 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013($0.20)($0.23)$0.75 million$1.99 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2013Q4 2012($0.19)($0.20)$0.32 million$1.99 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312($0.11)($0.37)$4.17 million$0.26 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/9/2012($0.20)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/15/2012($0.18)($0.30)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/14/2011($0.18)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2011($0.15)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Sunesis Pharmaceuticals (NASDAQ:SNSS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Sunesis Pharmaceuticals (NASDAQ:SNSS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/26/2016Geoffrey M ParkerDirectorBuy9,500$0.47$4,465.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Geoffrey M ParkerDirectorBuy52,505$0.47$24,677.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Dayton MisfeldtDirectorBuy1,750,000$0.84$1,470,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Daniel N Swisher JrCEOBuy12,216$1.01$12,338.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Daniel N Swisher JrCEOBuy12,784$1.01$12,911.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2014Forest BaskettMajor ShareholderSell266,700$7.97$2,125,599.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014Bay City Capital LlcMajor ShareholderSell300,700$7.98$2,399,586.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014Dayton MisfeldtDirectorSell200,000$7.89$1,578,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Adam R CraigCMOSell2,554$8.00$20,432.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Daniel N Swisher JrCEOSell5,000$8.00$40,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Dayton MisfeldtDirectorSell100,700$8.16$821,712.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Eric BjerkholtCFOSell10,000$8.00$80,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Krishna Kittu KolluriMajor ShareholderSell108,300$8.17$884,811.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Dayton MisfeldtDirectorSell743,700$6.64$4,938,168.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Equity Opportunities Fu GrowthMajor ShareholderSell710,540$6.63$4,710,880.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Sunesis Pharmaceuticals (NASDAQ:SNSS)
DateHeadline
06/30/16 06:43 PMSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Expected to Reach Highs Of $2.5 - Investor Newswire
06/29/16 09:14 AMSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Company Rating and Target Watch - Telanagana Press
06/27/16 10:35 AMShare Update and Earnings Review for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Press Telegraph
06/26/16 10:50 AMHow Analysts Feel About Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)? - Engelwood Daily
06/24/16 09:02 AMSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) Earnings Glance and Target Price Review - Engelwood Daily
06/24/16 09:02 AMCovering the Bases on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS): Where is the Stock Going? - Press Telegraph
06/24/16 09:02 AMStrong Sell Calls Recommendations For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) At 0 - Investor Newswire
06/24/16 09:02 AMSunesis Pharmaceuticals, Inc. (SNSS) Current Analyst Ratings - Fiscal Standard
06/22/16 06:26 PMSunesis Pharmaceuticals: Qinprezo/Dacogen Combo Stands Up
06/22/16 11:07 AMSunesis Pharmaceuticals Inc. (SNSS) Jumps 8.73% on June 20 - Equities.com
06/21/16 10:47 AMBiotech Unusual Volume: Epizyme, Inc. (NASDAQ:EPZM), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), Concert ... - KC Register
06/21/16 07:45 AMSunesis Pharmaceuticals (SNSS) in Focus: Stock Gains 8.7% -
06/16/16 06:42 PMStrong Buy Calls Count For Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) At 1 - Investor Newswire
06/14/16 06:08 PMCompany Update (NASDAQ:SNSS): Sunesis Pharmaceuticals, Inc. Announces Presentation of Positive Clinical ... - Smarter Analyst
06/13/16 09:28 AMSunesis Pharmaceuticals Announces Presentation of Positive Results from MD Anderson Sponsored Trial
06/13/16 06:59 AMSunesis Pharmaceuticals Announces Presentation of Positive Results from MD Anderson Sponsored Trial in Frontline Elderly AML and MDS at the EHA Annual Meeting - [at noodls] - SOUTH SAN FRANCISCO, Calif., June 13, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals (NASDAQ:SNSS) today announced the presentation of updated results from an ongoing Phase 1b/2 University of Texas MD ...
06/11/16 09:25 AMSunesis Pharmaceuticals Inc. (SNSS) Drops 5.87% on June 09 - Equities.com
06/09/16 08:42 AMMost Popular Healthcare Penny Stocks Among Hedge Funds -
06/08/16 03:14 PMSUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/08/16 09:34 AMSunesis Pharmaceuticals Inc. (SNSS) is Trading Lower on Unusual Volume for June 06 - Equities.com
06/06/16 04:43 PMETF’s with exposure to Sunesis Pharmaceuticals, Inc. : June 6, 2016 -
06/06/16 09:08 AMSunesis Announces Study Examining the Value of Complete Remission Prior to HCT in Patients with AML Presented at 2016 ASCO Annual Meeting - [at noodls] - SOUTH SAN FRANCISCO, Calif., June 06, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced the presentation of results from a study conducted by the Center for International ...
06/04/16 06:35 PMAnalyst Recommended These Stocks to Buy: TiVo Inc. (NASDAQ:TIVO), Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Beacon Chronicle
06/04/16 09:29 AMSunesis Pharmaceuticals Inc. (SNSS) is Trading Higher on Unusual Volume for June 02 - Equities.com
06/03/16 09:29 AMNew VP Could Help Save Shareholders In Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Scibility Media
06/02/16 06:58 PMBuy, Sell Or Hold Rating For Sunesis Pharmaceuticals, Inc. (SNSS)? - Share Trading News - Buy, Sell Or Hold Rating For Sunesis Pharmaceuticals, Inc. (SNSS)?Share Trading News07/24/2015 – Sunesis Pharmaceuticals, Inc. was downgraded to “sell” by analysts at Roth Capital. They now have a USD 1 price target on the stock. 07/24/2015 – Sunesis Pharmaceuticals, Inc. was downgraded to “market perform” by analysts at Cowen.Insiders Are Gradually Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)HNNall 2 news articles »
06/02/16 09:41 AMTarget Price and Stock Performance Rundown for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - HNN - Target Price and Stock Performance Rundown for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)HNNDuring the latest trading session, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) shares traded +1.0200%. Monitoring the stock price relative to moving averages may offer enhanced perspective on stock performance. After a recent check, shares have been ...and more »
06/02/16 09:41 AMInsiders Are Gradually Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - HNN - Insiders Are Gradually Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)HNNAccording to the latest SEC filings, insiders at Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) have increased their position in the stock by 337.94% over the past 6 months. Insiders now own 0.40% of total outstanding shares. There are both legal and ...and more »
06/01/16 07:08 PMStock Update (NASDAQ:SNSS): Sunesis Pharmaceuticals, Inc. Appoints Linda Neuman, MD, as Vice President ... - Smarter Analyst - Stock Update (NASDAQ:SNSS): Sunesis Pharmaceuticals, Inc. Appoints Linda Neuman, MD, as Vice President ...Smarter AnalystSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced that Linda Neuman, M.D., has been appointed to the role of Vice President, Clinical Development. Dr. Neuman brings 10 years of clinical practice and 13 years of industry experience to Sunesis, ...and more »
06/01/16 09:28 AMStocks inside Analysts Spotlight: Amarin Corporation PLC (NASDAQ:AMRN) , Sunesis Pharmaceuticals, Inc. (NASDAQ ... - Street Updates - Stocks inside Analysts Spotlight: Amarin Corporation PLC (NASDAQ:AMRN) , Sunesis Pharmaceuticals, Inc. (NASDAQ ...Street UpdatesIn the past trading session, Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) highlighted upward shift of +6.34% or +0.03 points to $0.50. The company traded a volume of 1.98 million shares over average volume of 230.95 thousand shares. Trailing twelve ...and more »
06/01/16 09:28 AMInsider Buying Roundup: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - The Point Review - Insider Buying Roundup: Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)The Point ReviewSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) insiders have most recently took part in a trading activity. On 5/26/2016 Parker Geoffrey M, Director bought 9,500 shares having total worth of $4,455 at the price of $0.47 per share, following the ...and more »
06/01/16 06:53 AMSunesis Pharmaceuticals Appoints Linda Neuman, M.D., as Vice President, Clinical Development - [at noodls] - SOUTH SAN FRANCISCO, Calif., June 01, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that Linda Neuman, M.D., has been appointed to the role of Vice President, Clinical ...
05/31/16 06:53 PMHealthcare Stocks under Discussion: Celator Pharmaceuticals Inc (NASDAQ:CPXX), Sunesis Pharmaceuticals, Inc ... - The Point Review - The Point ReviewHealthcare Stocks under Discussion: Celator Pharmaceuticals Inc (NASDAQ:CPXX), Sunesis Pharmaceuticals, Inc ...The Point ReviewSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) on May 25, 2016 announced its support for the first-ever Acute Myeloid Leukemia Awareness Month to be held in June. The goal of the campaign, which is being sponsored by CancerCare, is to put a spotlight ...and more »
05/31/16 06:53 PMSunesis Pharmaceuticals Inc. (SNSS) Jumps 6.34% on May 31 - Equities.com - Sunesis Pharmaceuticals Inc. (SNSS) Jumps 6.34% on May 31Equities.comSunesis Pharmaceuticals Inc. (SNSS) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 6.34% to $0.50, representing a gain of $0.0298 per share. Some 1.98 million shares traded hands on 1,589 trades, compared ...and more »
05/29/16 06:32 PMPerformance at a Glance on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - HNN - Performance at a Glance on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)HNNWhen speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)'s stock has performed at various points in its past ...
05/27/16 05:08 AMSUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or -
05/26/16 06:49 PMSunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in June - GlobeNewswire (press release) - Sunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in JuneGlobeNewswire (press release)SOUTH SAN FRANCISCO, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced its support for the first-ever Acute Myeloid Leukemia Awareness Month to be held in June. The goal of the campaign, ...and more »
05/26/16 07:09 AMInsiders Are Gradually Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Wall Street Hints and News - Insiders Are Gradually Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) have increased their position in the stock by 304.19% over the past 6 months. Insiders now own 0.40% of total outstanding shares. There are both legal and ...and more »
05/25/16 10:16 AMCompany Update (NASDAQ:SNSS): Sunesis Pharmaceuticals, Inc. Announces Support of First-Ever Acute Myeloid ... - Smarter Analyst - Company Update (NASDAQ:SNSS): Sunesis Pharmaceuticals, Inc. Announces Support of First-Ever Acute Myeloid ...Smarter AnalystSunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) announced its support for the first-ever Acute Myeloid Leukemia Awareness Month to be held in June. The goal of the campaign, which is being sponsored by CancerCare, is to put a spotlight on the disease, ...Sunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in JuneNasdaqall 3 news articles »
05/25/16 08:56 AMSunesis Pharmaceuticals Announces Support of First-Ever Acute Myeloid Leukemia Awareness Month in June - [at noodls] - Sunesis Provides Educational Grant to Support Campaign Sponsor CancerCare SOUTH SAN FRANCISCO, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced its support ...
05/23/16 11:50 AMAfter Last Week What Do Analysts Think Of Sunesis Pharmaceuticals, Inc. (SNSS) - Share Trading News - After Last Week What Do Analysts Think Of Sunesis Pharmaceuticals, Inc. (SNSS)Share Trading News05/09/2014 – Sunesis Pharmaceuticals, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of Sunesis Pharmaceuticals, Inc. (SNSS) was down -4.94% during the last trading session, with a day high of 0.52. 123256 shares were traded on ...
05/22/16 11:23 AMAlpha One Assigns Impact Score Of 87 To Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - RealistInvestor.com - Alpha One Assigns Impact Score Of 87 To Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)RealistInvestor.comAlpha One analyzed the various web articles published on Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), and thereafter it gave company a daily sentiment score of 0. The entity designs algorithm based assessment to known stock sentiment on stock after ...and more »
05/19/16 06:58 PMETF’s with exposure to Sunesis Pharmaceuticals, Inc. : May 19, 2016 -
05/19/16 10:10 AMShare Performance and Target Price Review for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Wall Street Hints and News - Share Performance and Target Price Review for Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)Wall Street Hints and NewsLooking at stock activity from multiple angles may be of benefit when examining share performance. Investors have the ability to focus in on short or long term share performance. During the most recent trading session, Sunesis Pharmaceuticals, Inc.and more »
05/19/16 10:10 AMInsiders Are Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) - Wall Street Hints and News - Insiders Are Buying Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) have increased their position in the stock by 321.46%. Insiders now own 0.40% of total outstanding shares. There are both legal and illegal types of insider ...and more »
05/19/16 07:32 AMSunesis Pharmaceuticals Announces Oral Presentation on Vosaroxin at the 21st Congress of the European Hematology Association - [at noodls] - SOUTH SAN FRANCISCO, Calif., May 19, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced an oral presentation on vosaroxin at the 21Congress of the European Hematology ...
05/18/16 12:56 PMSunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/18/16 11:00 AMSunesis Pharmaceuticals Inc. (SNSS) Hits New 52-week Low During May 16 Session - Equities.com - Sunesis Pharmaceuticals Inc. (SNSS) Hits New 52-week Low During May 16 SessionEquities.comSunesis Pharmaceuticals Inc. (SNSS) established a new 52-week low yesterday, and could be a company to watch at the open. After opening at $0.46, Sunesis Pharmaceuticals Inc. dropped to $0.44 for a new 52-week low. By the closing bell, the company's ...
05/18/16 07:02 AMSunesis to Present at the 2016 UBS Global Healthcare Conference - [at noodls] - SOUTH SAN FRANCISCO, Calif., May 18, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at the 2016 ...
05/17/16 11:34 PMSunesis Pharmaceuticals Inc. (SNSS) Jumps 6.52% on May 16 - Equities.com - Sunesis Pharmaceuticals Inc. (SNSS) Jumps 6.52% on May 16Equities.comSunesis Pharmaceuticals Inc. (SNSS) was among the biggest gainers on the Russell 2000 for Monday May 16 as the stock popped 6.52% to $0.49, representing a gain of $0.03 per share. Some 216,834 shares traded hands on 309 trades, compared with an ...and more »
About Sunesis Pharmaceuticals

Sunesis Pharmaceuticals logoSunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company's program is QINPREZOTM (vosaroxin), which is its product candidate for the treatment of acute myeloid leukemia (AML). Vosaroxin is an anticancer quinolone derivative (AQD), which is a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin is an AQD, which is used for the treatment of cancer. MLN2480 is an oral, investigative drug selective for pan-Raf kinase inhibition, in patients with relapsed or refractory solid tumors. SNS-062 is a non-covalently binding inhibitor of Bruton's tyrosine kinase (BTK). PDK1 is a kinase and mediator of PI3K/AKT signaling, which is a pathway involved in cell growth, differentiation, survival and migration.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SNSS
  • CUSIP: 86732860
Key Metrics:
  • Previous Close: $0.55
  • 50 Day Moving Average: $0.5271
  • 200 Day Moving Average: $0.6503
  • P/E Ratio: N/A
  • P/E Growth: -0.0100
  • Market Cap: $47.61M
  • Current Quarter EPS Consensus Estimate: $-0.4200 EPS
Additional Links:
Sunesis Pharmaceuticals (NASDAQ:SNSS) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha